Delhi HC Orders Action Against Spurious Oxytocin Use In Dairy Colonies
New Delhi: The Delhi High Court has ordered State authorities to take action against the spurious use of oxytocin on cattle in dairy colonies in the Capital. It noted that…
NPPA Revises Ceiling Price Of Coronary Stents In Tune With WPI
New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has revised the ceiling prices of coronary stents with effect from the beginning of April, 2024, in tune with the Wholesale Price Index…
AstraZeneca Reaffirms Safety Of Covishield, Vaxzevria Vaccines Amid Blood Clot Concerns
Cambridge: Amid recent concerns over potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reaffirmed its dedication to patient safety, while underscoring its overall safety profile.…
DCA Officials Seize ‘Colinol-Spas Tab’ For Misleading Claim
HYDERABAD: Officials of Drugs Control Administration, Telangana seized ‘Colinol-SPAS Tablets (Mefenamic Acid and Dicyclomine Hydrochloride Tablets IP)’, an allopathic medicine, in Nampally, Hyderabad, for making a misleading advertisement claiming it…
FTC Targeting More Than 300 Junk Listings For Diabetes, Weight Loss, Asthma And COPD Drugs
WASHINGTON: The Federal Trade Commission expanded its campaign against pharmaceutical manufacturers’ improper or inaccurate listing of patents in the Food and Drug Administration’s (FDA) Orange Book, disputing junk patent listings…
DCA Officials Seize Ayurvedic Medicines Over Misleading Claims
HYDERABAD: Drugs Control Administration, Telangana, officials seized ayurvedic medicines for misleading advertisements and an unauthorized slimming and cosmetics private limited, overpriced medicines and a quack in various parts of the state…
Sugar Content In Cerelac Lower Than FSSAI Limit: Nestle
Mumbai: Nestle India on Monday rejected the charges relating to the company selling baby food products like Cerelac with higher sugar content in less developed countries like India. Chairman and…
Uttarakhand Suspends Permissions Of 14 Products Of Ramdev’s Pharma Firms
Haridwar: An Indian state regulator has suspended manufacturing licences of 14 products made by pharmaceutical companies of the country’s most popular yoga guru for repeatedly publishing misleading advertisements about their efficacy,…
Patanjali Group Firms Under DGGI Scanner For Non-Payment Of GST, Fake ITC
New Delhi: Fresh troubles seem to be in the offing for Patanjali Group companies led by Baba Ramdev. Directorate General for GST Intelligence (DGGI) is understood to have issued 2 show-cause…
Indian Industry Should Focus On Business Risk Mitigation Initiatives To Grab Global Opportunities: DoP Study
New Delhi: The Indian pharmaceutical industry needs to focus on various measures including investment in incremental innovation, market and product differentiation, cost reduction and improving efficiency, partnership for technology, market…
